Three ‘buys,’ three ‘sells,’ and a ‘hold,’ by Oppenheimer analysts

Oppenheimer analysts provided insights into seven stocks this morning in a note.

Buy-rated stocks:

• Modine Manufacturing Co. (NYSE:MOD) – The stock continues to have a bullish slope.
• Tandem Diabetes Care Inc. (TNDM) – The stock is reversing its multi-year downtrend, analysts said.
• RxSight Inc. (RXST) – The stock has an intact bullish trend.

Sell-rated stocks:

• Edwards Lifesciences Corp. (NYSE:EW) – Analysts said that July’s downtrend is a showing a resumption of a longer-term trend.
• DexCom Inc. (DXCM) – July’s losses marks “a potential completion of a multi-year topping process,” analysts wrote.
• A. O. Smith Corp. (AOS) – The stock’s rollover below its 200-day average is “concerning,” because it happened at the marking of its 2021 peak (at $87).

A Hold stock:

• Zurn Elkay Water Solutions Corp. (ZWS) – The stock is showing a “mid-ranked momentum score,” analysts said. Above its $31 support, a more positive trend could form, and analysts see $34 “as a formidable resistance.”